Master of Science (MS)
Program or Discipline Name
Health Care Professionals (HCPs) play a vital role in the early detection, assessment and reporting of Adverse Drug Reactions (ADRs) to the Regulatory Health Authority or Pharmaceutical Manufacturer. It’s always important that HCPs should improve continuously about their knowledge, attitude and their practice towards Pharmacovigilance and ADR reporting. The main goal of the research study is to evaluate whether if pharmacovigilance training provided by the Pharmaceutical Company will improve the HCP’s knowledge, their attitude and practice improves towards Pharmacovigilance and ADR reporting (Alan, Melike, Sule , Burcu, & Yusuf , 2013). The training is provided through the electronic learning management system. The learning management system (LMS) will be implemented using the Waterfall Methodology (Foreman, 2013).
Nukala, S. (2017). Pharmacovigilance: The Role Of Pharmaceutical Companies To Protect Patients From Adverse Drug Reactions. Retrieved from https://digitalcommons.harrisburgu.edu/pmgt_dandt/21